PTEN and glioblastoma: However, our major finding was that glioblastoma cells harboring an alteration in the phosphatase domain of PTEN, one of the main negative regulators of the PI3K/AKT pathway, were sensitive to AKT inhibition by capivasertib with respect to cell proliferation and cell survival, but not to galvanotactic migration.